Volume 13, Issue 11, November 2026

Antimicrobial Resistance

Major Article

Lea A Nikolai and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag666, https://doi.org/10.1093/ofid/ofag666

In a tertiary care setting, intravenous-to-oral antibiotic switch (IVOS) was underused in clinically stable patients with bloodstream infection. Implementation barriers included comorbid conditions, more severe disease, and nonurogenital focus. Patients with IVOS had shorter hospital stays and a lower mortality rate.

Clinical Trials and Therapeutics

Major Articles

Erin T Ruiter and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag681, https://doi.org/10.1093/ofid/ofag681
Jill Blumenthal and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag628, https://doi.org/10.1093/ofid/ofag628

Transgender individuals both on and off gender-affirming hormone therapy (GAHT) had similar preexposure prophylaxis (PrEP) concentrations after 12 weeks of daily oral emtricitabine–tenofovir disoproxil fumarate (FTC/TDF) PrEP use. Hormone concentrations were not significantly different with or without FTC/TDF PrEP, and there were no changes in the perceived effect on GAHT in those taking PrEP.

Lauren T Harven and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag662, https://doi.org/10.1093/ofid/ofag662

Outpatient prescribing for dental infections across a health system revealed an overall preference for first-line penicillins and an opportunity to improve prescribing of beta-lactams in patients with and without reported allergies. Clindamycin and cefdinir were independently associated with treatment failure.

Brief Reports

Brett Faine and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag705, https://doi.org/10.1093/ofid/ofag705

This multi-center, double-blind, pilot randomized controlled trial evaluated whether patient-direction antibiotic duration, guided by symptom resolution, would achieve similar sustained clinical resolution at 30 days and comparable adverse event rates to fixed-duration treatment among women with pyelonephritis. Sustained clinical resolution rates and adverse events were similar between the two groups, supporting the feasibility of this strategy and justification of a larger, adequately powered randomized trial to further evaluate its efficacy and safety.

Nicole Poovan and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag612, https://doi.org/10.1093/ofid/ofag612
Ryan M Nguyen and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag690, https://doi.org/10.1093/ofid/ofag690

  • Fifteen of 18 (83.3%) of participants treated with oral linezolid 600 mg twice daily for 10 days showed adequate serological response by 6 months.

  • No serious adverse events were reported.

  • Larger clinical trials are necessary to evaluate efficacy.

Diagnostic Methods and Tools

Major Articles

Jeffrey I Campbell and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag672, https://doi.org/10.1093/ofid/ofag672

In this US community healthcare cohort, 1 in 7 individuals with a positive IGRA received ≥1 additional test; 51% of repeat tests were likely not indicated based on current recommendations. Reversion was uncommon when initial IGRA results were strongly positive.

Jiaao Wang and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag724, https://doi.org/10.1093/ofid/ofag724
Matthew A Butzler and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag706, https://doi.org/10.1093/ofid/ofag706

  • An automated near-point-of-care test for Mycobacterium tuberculosis for tongue swab and sputum specimens was developed.

  • The test had high sensitivity and specificity with banked specimens.

  • The platform is compatible with settings that lack consistent electricity and air conditioning.

Brief Reports

Wesley D Kufel and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag700, https://doi.org/10.1093/ofid/ofag700
Safa Ben Brahim and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag720, https://doi.org/10.1093/ofid/ofag720
Pei Min Thong and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag722, https://doi.org/10.1093/ofid/ofag722

Epidemiology and Disease Surveillance

Major Articles

Joshua A Salomon and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag669, https://doi.org/10.1093/ofid/ofag669

This study updates methods to estimate true viral hepatitis infections from reported cases by accounting for asymptomatic infections, healthcare-seeking behavior, and jurisdiction-specific surveillance capacity. The approach reveals substantial under-reporting, with adjustment factors varying widely across jurisdictions, particularly for acute hepatitis C.

Peter G Beckwith and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag715, https://doi.org/10.1093/ofid/ofag715

Among patients with newly diagnosed rifampin-resistant tuberculosis (RR-TB) and bedaquiline resistance (BDQ-R), 55% had no prior exposure to bedaquiline, suggesting primary transmission. Treatment outcomes in patients with BDQ-R RR-TB were poor, although better in patients with primary than acquired BDQ-R.

Nathalie Karaky and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag676, https://doi.org/10.1093/ofid/ofag676
José I Bernardino and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag686, https://doi.org/10.1093/ofid/ofag686

In 1134 ART-naive people with HIV, INSTI-based first-line therapy was independently associated with incident hypertension compared with NNRTIs, an effect driven by dolutegravir-containing regimens (>2-fold 5-year hazard) and only partially explained by BMI, supporting routine blood pressure surveillance after ART initiation.

Mami Ishikuro and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag678, https://doi.org/10.1093/ofid/ofag678

In this population-based Japanese cohort, CMV seroprevalence plateaued by adulthood, whereas EBV approached near-universal seropositivity. These distinct age-related patterns provide epidemiologic evidence relevant to public health planning and to evaluation of future preventive strategies, including vaccination and screening approaches.

Teresa H Evering and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag577, https://doi.org/10.1093/ofid/ofag577
Jennifer E Balkus and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag714, https://doi.org/10.1093/ofid/ofag714
Kara Wegermann and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag729, https://doi.org/10.1093/ofid/ofag729

Global Health and Infectious Diseases

Major Article

Caleb P Skipper and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag668, https://doi.org/10.1093/ofid/ofag668

Cytomegalovirus viremia is associated with high mortality in HIV-associated cryptococcal meningitis. We found that CMV viremia is associated with slower clearance of Cryptococcus yeast from the CSF and lower probability to sterilize CSF after antifungal induction therapy.

Healthcare-Associated Infections

Major Articles

Syeda Mah-E-Muneer and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag647, https://doi.org/10.1093/ofid/ofag647
Laura Alagna and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag677, https://doi.org/10.1093/ofid/ofag677

Among 406 patients receiving invasive mechanical ventilation for non-pulmonary indications in 8 Italian intensive care units, ventilator-associated pneumonia (VAP) developed in more than one-third of patients within 15 days. Non-neurologic admission, female sex and early antibiotic exposure were associated with lower incidence, and VAP showed no significant association with 30-day mortality.

Luis Asdruval Zepeda-Gutiérrez and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag723, https://doi.org/10.1093/ofid/ofag723

  • Septic shock and mechanical ventilation predicted 30-day mortality; empiric antifungal therapy was associated with lower odds (aOR 0.45).

  • Exploratory WISCA: fluconazole coverage <80% at 3/4 analytic centers; micafungin >97% at all 4.

  • Nonculture diagnostics were unavailable at all 6 centers.

ID Public Health and Health Policy

Review Article

Jeanne Bertolli and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag687, https://doi.org/10.1093/ofid/ofag687

Brief Report

Daniel Resnick and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag680, https://doi.org/10.1093/ofid/ofag680

Perspectives

Jessica Crooker and Saravanan Thangamani
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag710, https://doi.org/10.1093/ofid/ofag710

Infection Prevention and Control

Major Article

Eric Mulume Musafiri and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag725, https://doi.org/10.1093/ofid/ofag725

Brief Reports

Oliver Martyn and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag536, https://doi.org/10.1093/ofid/ofag536
Elizabeth A Scruggs-Wodkowski and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag708, https://doi.org/10.1093/ofid/ofag708

Infectious Diseases in Special Populations

Major Articles

Kathleen E Hurwitz and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag630, https://doi.org/10.1093/ofid/ofag630
Elizabeth Whidden and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag689, https://doi.org/10.1093/ofid/ofag689

Among people with HIV and substance use disorder, initiating long-acting cabotegravir-rilpivirine in a low-barrier clinic significantly improved viral suppression, increased medication for opioid use disorder uptake, reduced opioid use, and maintained high treatment engagement over 6 months.

Kap Sum Foong and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag693, https://doi.org/10.1093/ofid/ofag693
Kanokkarn Pinyopornpanish and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag704, https://doi.org/10.1093/ofid/ofag704
Luis Ramos-Ruperto and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag719, https://doi.org/10.1093/ofid/ofag719

Brief Reports

Hugo Bes-Berlandier and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag683, https://doi.org/10.1093/ofid/ofag683
Stephanie T Batch and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag721, https://doi.org/10.1093/ofid/ofag721

Microbiology and Pathogenesis

Major Article

Iris D N Van Bommel and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag685, https://doi.org/10.1093/ofid/ofag685

This multicenter study focusing on Staphylococcus aureus bacteremia highlights opportunities to reduce excessive blood culturing during patient follow-up. Half of all follow-up blood culture sets met at least one potential diagnostic stewardship criterion, suggesting opportunities to optimize culturing frequency and duration while ensuring adequate documentation of bacterial clearance.

Tropical and Emerging Infectious Diseases

Major Article

Ana Catharina S S Nastri and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag638, https://doi.org/10.1093/ofid/ofag638

Severe yellow fever may present without classical features such as fever and jaundice in its early phase. Recognizing these atypical presentations may improve clinical suspicion and support earlier diagnosis and management in endemic settings.

Brief Report

Monica Pachar-Flores and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag648, https://doi.org/10.1093/ofid/ofag648

Vaccines and Immunization

Major Article

Jennifer Moore and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag679, https://doi.org/10.1093/ofid/ofag679

mRNA-1345, an mRNA-based RSV vaccine, was well tolerated and immunogenic in children aged 2 to <18 years, including high-risk groups. Findings support further clinical development of mRNA-1345 in seropositive pediatric patients at risk for more severe RSV disease.

Perspectives

Dawd S Siraj and Fauzia Hollnagel
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag694, https://doi.org/10.1093/ofid/ofag694

Correspondence

Sheridan D George and others
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag688, https://doi.org/10.1093/ofid/ofag688
F Bos and H Kaminski
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag652, https://doi.org/10.1093/ofid/ofag652

Corrections

Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag695, https://doi.org/10.1093/ofid/ofag695
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag746, https://doi.org/10.1093/ofid/ofag746
Open Forum Infectious Diseases, Volume 13, Issue 11, November 2026, ofag747, https://doi.org/10.1093/ofid/ofag747